Mach7 Technologies (ASX:M7T) ROCE % : -17.94% (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Mach7 Technologies ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Mach7 Technologies's annualized ROCE % for the quarter that ended in Dec. 2023 was -17.94%.

Mach7 Technologies ROCE % Historical Data

The historical data trend for Mach7 Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mach7 Technologies ROCE % Chart

Mach7 Technologies Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROCE %

Get a 7-Day Free Trial

-52.23

-1.63

-18.61

-9.10

-25.24

Mach7 Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial															-4.23	-13.86	-4.07	-47.34	-17.94

Mach7 Technologies ROCE % Calculation

Mach7 Technologies's annualized ROCE % for the fiscal year that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	-17.167	/	( ( (78.922 - 10.387)	+	(82.306 - 14.831) )	/ 2 )
	=	-17.167	/	( (68.535	+	67.475)	/ 2 )
	=	-17.167	/	68.005
	=	-25.24 %

Mach7 Technologies's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-11.54	/	( ( (82.306 - 14.831)	+	(73.788 - 12.579) )	/ 2 )
	=	-11.54	/	( ( 67.475	+	61.209 )	/ 2 )
	=	-11.54	/	64.342
	=	-17.94 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Mach7 Technologies (ASX:M7T) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Mach7 Technologies ROCE % Related Terms

Thank you for viewing the detailed overview of Mach7 Technologies's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Mach7 Technologies (ASX:M7T) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mach7 Technologies Ltd (ASX:M7T) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

120 Kimball Avenue, Suite 210, South Burlington, VT, USA, 05403

Website

https://www.mach7t.com

Mach7 Technologies Ltd is engaged in enterprise imaging data sharing, storage, and interoperability for healthcare enterprises globally. The principal activity of the Company is the development and commercialisation of medical imaging and data, management software solutions for global healthcare enterprises The company's operating segment includes Software licenses and Professional services. It generates maximum revenue from the Software licenses segment. Geographically, it derives a majority of its revenue from North America and also has a presence in the Middle East; Asia/Pacific and Europe, and other regions. The company's solutions include Management Studio; Diagnostic Studio; and Clinical Studio.

Mach7 Technologies (ASX:M7T) Headlines

No Headlines